Novartis Venture Fund
We invest in companies developing novel therapeutics and platforms.
Basel, Switzerland · 62+ investments · 46 portfolio companies
- Headquarters
- Basel, Switzerland
- Founded
- 1996
- Website
- nvfund.com
- AUM
- $750.0M
- Portfolio Companies
- 46
- Total Investments
- 62
- Last Investment
- Aug 2026
- Geographic Focus
- North America, Europe, Global, Asia, Canada, United States
Indexed holds 46 portfolio companies and 62 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Novartis Venture Fund is a Corporate VC firm based in Basel, Switzerland. It has made 62 investments, including NRG Therapeutics, Syneron Bio and EXO Therapeutics. Focus areas include Biotech and Life Sciences.
Portfolio46
Co-investors24
Sign up to view co-investors
24 co-investors across 99 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Corporate VC ×3 · Hedge Fund ×2 · 70 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/novartis-venture-fund"><img src="https://indexed.vc/api/badge/investor/novartis-venture-fund" alt="Novartis Venture Fund on Indexed.vc" width="260" height="76" /></a>